Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Rosa F. Hwang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3103-6511; OpenAlex author ID A5004489071; NIH RePORTER profile ID 2053465. Sources: OpenAlex.

Their work

Papers
23 (first author 1, last author 1)
Trials
0
Grants
3
Labs led
1
Collaborators
120
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers, 1 grant · 2013: 1 paper, 1 grant · 2014: 2 papers · 2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: 3 papers, 1 grant · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: 1 paper

Papers 23

  1. Therapeutic Eradication of Cancer-associated Fibroblasts Inhibits in vivo progression of Pancreatic Cancer Co-author DOI 10.1101/2025.11.04.686484↗
  2. Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer. Co-author DOI 10.1038/s41421-024-00720-w↗
  3. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Co-author DOI 10.1038/s41556-024-01372-4↗
  4. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … Co-author DOI 10.1038/s41556-024-01417-8↗
  5. Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer. Co-author DOI 10.3390/cells12111490↗
  6. Role of stromal activin A in human pancreatic cancer and metastasis in mice. Co-author DOI 10.1038/s41598-021-87213-y↗
  7. Iron and Lipocalin-2 Modulate Cellular Responses in the Tumor Micro-environment of Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/2020.01.14.907188↗
  8. Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. Co-author DOI 10.1667/rr15189.1↗
  9. Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Co-author DOI 10.1016/j.canlet.2018.01.057↗
  10. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. Co-author DOI 10.1073/pnas.1722434115↗
  11. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Last author DOI 10.1126/scitranslmed.aat3487↗
  12. Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/labinvest.2016.146↗
  13. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment. Co-author DOI 10.1158/0008-5472.can-16-1986↗
  14. Generation of an in vitro 3D PDAC stroma rich spheroid model. Co-author DOI 10.1016/j.biomaterials.2016.08.041↗
  15. Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. Co-author DOI 10.1158/0008-5472.can-16-0715↗
  16. Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells. Co-author DOI 10.1021/mp500875f↗
  17. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts. Co-author DOI 10.1038/onc.2013.68↗
  18. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Co-author DOI 10.1158/1535-7163.mct-14-0028↗
  19. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. First author DOI 10.1158/0008-5472.can-12-4479↗
  20. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Co-author DOI 10.1158/1541-7786.mcr-12-0022↗
  21. Molecular profiling of direct xenograft tumors established from human pancreatic adenocarcinoma after neoadjuvant therapy. Co-author DOI 10.1245/s10434-011-1839-4↗
  22. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Co-author DOI 10.1097/mpa.0b013e31821f6927↗
  23. Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment. Co-author DOI 10.1158/1535-7163.mct-11-0261↗

Grants 3

  1. Inhibition of Stromal-Derived DKK3 to Enhance the Response of Pancreatic Cancer to Immunotherapy R21CA218495↗
  2. Stromal Periostin in Pancreatitis and Pancreas Cancer K08CA138912↗
  3. Conditional ablation of stellate cells to determine their role in pancreatitis an R21CA155650↗

Closest collaborators

The 25 strongest of 120 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huamin Wang · 6 shared papers, 2012–2024 · strength 0.36
  2. Craig D. Logsdon · 7 shared papers, 2011–2018 · strength 0.28
  3. Kamiya Mehla · 2 shared papers, 2024 · strength 0.28
  4. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  5. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  6. Divya Murthy · 2 shared papers, 2024 · strength 0.28
  7. Tuo Hu · 2 shared papers, 2024 · strength 0.28
  8. Aneesha Dasgupta · 2 shared papers, 2024 · strength 0.28
  9. Chunbo He · 2 shared papers, 2024 · strength 0.28
  10. Robert Powers · 2 shared papers, 2024 · strength 0.28
  11. Teklab Gebregiworgis · 2 shared papers, 2024 · strength 0.28
  12. Nina V. Chaika · 2 shared papers, 2024 · strength 0.28
  13. Scott E. Mulder · 2 shared papers, 2024 · strength 0.28
  14. Joshua J. Souchek · 2 shared papers, 2024 · strength 0.28
  15. Sai Sundeep Kollala · 2 shared papers, 2024 · strength 0.28
  16. Barish H. Edil · 2 shared papers, 2024 · strength 0.28
  17. Ryan J. King · 2 shared papers, 2024 · strength 0.28
  18. Ravi Kumar Thakur · 2 shared papers, 2024 · strength 0.28
  19. Pankaj Kumar Singh · 2 shared papers, 2024 · strength 0.28
  20. Michael Anthony Hollingsworth · 2 shared papers, 2024 · strength 0.28
  21. Kathryn Elaine Wellen · 2 shared papers, 2024 · strength 0.28
  22. Paul M. Grandgenett · 2 shared papers, 2024 · strength 0.28
  23. Surendra Kumar Shukla · 2 shared papers, 2024 · strength 0.28
  24. Amarnath (Amar) Natarajan · 2 shared papers, 2024 · strength 0.28
  25. Susanna Varkey Ulahannan · 2 shared papers, 2024 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.